ALT-946

Known as: N-(2-acetamidoethyl)hydrazinecarboximidamide 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2001-2015
0120012015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
CONTEXT Advanced Glycation End-Products (AGEs) are signaling proteins associated to several vascular and neurological… (More)
  • table 1
  • table 2
Is this relevant?
Review
2005
Review
2005
Prolonged hyperglycemia, dyslipidemia and oxidative stress in diabetes result in the production and accumulation of AGEs. It is… (More)
Is this relevant?
2002
2002
The severe diabetic nephropathy that develops in the hypertensive transgenic (mRen-2)27 rat with streptozotocin (STZ) diabetes… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Aims/hypothesis. ALT-946, an inhibitor of advanced glycation with a minimal inhibitory effect on nitric oxide synthase, was… (More)
Is this relevant?